A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.
about
Gadolinium-based nanoparticles for theranostic MRI-radiosensitizationLaser spectrometry for multi-elemental imaging of biological tissues.Bifunctional polypyridyl-Ru(II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy.Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents.Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy.Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells.Laser-induced breakdown spectroscopy: a new approach for nanoparticle's mapping and quantification in organ tissue.The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.Ultrasmall Nanoplatforms as Calcium-Responsive Contrast Agents for Magnetic Resonance Imaging.Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detectionAdvantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial.The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in TumorsGd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targetingEffect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cellsKey clinical beam parameters for nanoparticle-mediated radiation dose amplification.Safety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates.Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging.AGuIX nanoparticles as a promising platform for image-guided radiation therapy.Orotracheal administration of contrast agents: a new protocol for brain tumor targeting.Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.Evaluation of Novel 64Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude Mice.Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization.Temperature-responsive copolymer brush constructed on a silica microparticle by atom transfer radical polymerizationIn vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles
P2860
Q27027308-2F3B3563-CD8C-4644-A9E2-D5ED505C7FC0Q28654458-0927451E-5D6A-45C3-B7DE-5AD338583F0BQ30655635-9E77D387-D444-43CD-987D-284580F79062Q33835121-176CE457-7DF1-47E5-BF79-66408F1C5FB3Q33893840-B715470C-FC95-486E-8605-AF6DDD93AFB7Q34317730-420E6B6A-8875-4B1C-BBB7-0C76A94C8B18Q35194308-C1E79B2F-BA6E-4954-8C97-297011DC9750Q35676729-4B4C50CA-64C3-4247-B374-498414920DF4Q35693019-74F9D1B4-FA4B-4D0B-A93A-CB3F1B492137Q35986031-CAB40562-975B-462F-83C4-EB66F5681C22Q36245012-825A950A-9285-43B5-8CB7-6705C4EC6319Q36534202-DB8E5F18-39C9-4453-81E0-85EC55201D55Q37093101-15289E0F-943C-4606-8640-36DAE14CAFE4Q37126036-81891E58-7FBC-4947-AE8C-9F45B20BAFEEQ37133577-66F70AE5-560F-486F-B847-84D07822B0B9Q37278115-61C43233-D408-4A37-B9A9-FC369B16C4B7Q37325488-694B03D0-3C2B-4BBA-8782-37E35B4119A5Q37624164-3CD074D6-9AB7-48B9-806E-E165B0321DFBQ38246679-F83A2B2E-1BEE-4822-BA2B-06BB3E55AD3CQ38740522-AC037509-2F96-4E64-A876-A57F142C5C63Q38837229-54355F0C-9769-4492-BC52-758228681AC2Q38881146-1221409B-F18D-423E-8713-75D5DB22976BQ38931279-51F60442-CFC6-4E1E-BA72-DC71450E09F3Q41619308-904D92A4-CA0B-4F6C-8ADD-95C52E21F93CQ42280531-B92FE8BE-3D3D-4974-8B1D-17B1DDC4BF6DQ44709188-DB8963D6-2A06-457C-AD48-567D5A3B9312Q52647643-ED05FFE5-22E4-4467-AB71-C77A71C9F6E2Q52939850-FC5FCD24-078C-4FAD-B025-80A0E00121C7Q53452247-398C54F7-6FB3-4895-B4EC-3BF7F6F58575Q57346686-3CEA58A1-C0E1-4370-B65A-4ED4EF185F6CQ58032718-5122832A-AA82-4146-A218-B59FA0B2FC5C
P2860
A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A top-down synthesis route to ...... for theranostic applications.
@en
A top-down synthesis route to ...... for theranostic applications.
@nl
type
label
A top-down synthesis route to ...... for theranostic applications.
@en
A top-down synthesis route to ...... for theranostic applications.
@nl
prefLabel
A top-down synthesis route to ...... for theranostic applications.
@en
A top-down synthesis route to ...... for theranostic applications.
@nl
P2093
P2860
P50
P356
P1476
A top-down synthesis route to ...... s for theranostic applications
@en
P2093
Anna Mignot
Belen Albela
Cédric Louis
Dominique Luneau
Franck Denat
François Lux
Françoise Chuburu
Frédéric Boschetti
Gilles Lemercier
Géraldine Le Duc
P2860
P304
P356
10.1002/CHEM.201203003
P407
P50
P577
2013-03-19T00:00:00Z